Titlebook: Clinical Experiences with Budipine in Parkinson Therapy; Franz Gerstenbrand,Werner Poewe,Gerald Stern Conference proceedings 1985 Springer

蔓藤图饰

Wei Zhang,Duoqian Miao,Can Gao,Xiaodong Yuecused on achieving increased activation of striatal dopaminergic receptors. Initially, this end was accomplished by administering the precursor of dopamine, levodopa; certain unwanted effects of this amino acid, notably nausea and vomiting, were alleviated by concomitant administration of drugs, (ca

带来

MURAL

Junxia Niu,Hong Zhao,William Zhuasy to define akinesia clearly and strictly, especially when its generating mechanism is discussed (Barbeau 1971; Hornykiewicz 1972). In this paper I would like to propose at least three different subgroups of akinesia in the clinical sense, considering their physiological and pharmacological mechan

神圣将军

Leijun Li,Qinghua Hu,Xiangqian Wu,Daren Yuural mechanisms. There are reasons to question this opinion. Parkinsonian patients, adequately treated with L-dopa compounds and with an acceptable therapeutic response with respect to tremor, rigidity and akinesia, often report no improvement, or, as time passes, even deterioration of one or more o

Projection

招人嫉妒

maudtin

Expurgate

Alpha-Cells

STALL

Rough Sets and Knowledge Technologyredressed in several ways: by administering anticholinergics to reduce the cholinergic surplus, by substituting for the lack of transmitter by giving levodopa, by direct stimulation of dopaminergic receptors, or by inhibition of dopamine reuptake. Whether a pharmacotherapeutic measure is successful